相似文献
1
Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.系统性红斑狼疮的研究与治疗——传统疗法与新兴疗法
Rheumatology (Oxford). 2017 Apr 1;56(suppl_1):i100-i113. doi: 10.1093/rheumatology/kew417.
2
[Treatment of systemic lupus erythematosus: myths, certainties and doubts].[系统性红斑狼疮的治疗：误区、定论与疑问]
Med Clin (Barc). 2013 Dec 21;141(12):533-42. doi: 10.1016/j.medcli.2013.02.014. Epub 2013 Apr 23.
3
Update οn the diagnosis and management of systemic lupus erythematosus.红斑狼疮诊断与治疗的最新进展。
Ann Rheum Dis. 2021 Jan;80(1):14-25. doi: 10.1136/annrheumdis-2020-218272. Epub 2020 Oct 13.
4
It hasn't gone away: the problem of glucocorticoid use in lupus remains.它并未消失：狼疮中糖皮质激素的使用问题依然存在。
Rheumatology (Oxford). 2017 Apr 1;56(suppl_1):i114-i122. doi: 10.1093/rheumatology/kew406.
5
Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history.红斑狼疮和多发性硬化症并存：患病率、临床特征和自然病史。
Semin Arthritis Rheum. 2014 Jun;43(6):751-8. doi: 10.1016/j.semarthrit.2013.11.007. Epub 2013 Nov 13.
6
Immunotherapies in rheumatologic disorders.风湿性疾病的免疫治疗。
Med Clin North Am. 2012 May;96(3):475-96, ix-x. doi: 10.1016/j.mcna.2012.04.003. Epub 2012 May 1.
7
Emerging therapies in systemic lupus erythematous: from clinical trial to the real life.系统性红斑狼疮的新兴疗法：从临床试验到现实生活
Expert Rev Clin Pharmacol. 2016;9(5):681-94. doi: 10.1586/17512433.2016.1155446. Epub 2016 Mar 10.
8
Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study.系统性红斑狼疮标准治疗的免疫抑制剂与糖皮质激素的使用及疾病结局的相关性：一项多中心队列研究。
Adv Rheumatol. 2024 May 8;64(1):38. doi: 10.1186/s42358-024-00366-y.
9
Systemic lupus erythematosus diagnosis and management.系统性红斑狼疮的诊断与管理。
Rheumatology (Oxford). 2017 Apr 1;56(suppl_1):i3-i13. doi: 10.1093/rheumatology/kew401.
10
How to treat refractory arthritis in lupus?如何治疗狼疮性难治性关节炎？
Joint Bone Spine. 2012 Jul;79(4):347-50. doi: 10.1016/j.jbspin.2011.12.010. Epub 2012 Feb 14.
引用本文的文献
1
A rationally designed CD19 monoclonal antibody-triptolide conjugate for the treatment of systemic lupus erythematosus.一种用于治疗系统性红斑狼疮的合理设计的CD19单克隆抗体-雷公藤内酯醇偶联物。
Acta Pharm Sin B. 2024 Oct;14(10):4560-4576. doi: 10.1016/j.apsb.2024.06.024. Epub 2024 Sep 3.
2
Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics.了解I型干扰素在皮肤型红斑狼疮和皮肌炎中的作用：迈向更好的治疗方法。
Arthritis Rheumatol. 2025 Jan;77(1):1-11. doi: 10.1002/art.42983. Epub 2024 Oct 29.
3
Beneficial effects of rapamycin on endothelial function in systemic lupus erythematosus.雷帕霉素对系统性红斑狼疮患者内皮功能的有益作用。
Front Physiol. 2024 Aug 21;15:1446836. doi: 10.3389/fphys.2024.1446836. eCollection 2024.
4
Exploring the ROS reduction strategies in chronic lupus management.探索慢性狼疮管理中的活性氧减少策略。
Front Immunol. 2024 Feb 20;15:1346656. doi: 10.3389/fimmu.2024.1346656. eCollection 2024.
5
Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial.霉酚酸酯撤药治疗系统性红斑狼疮患者的多中心、开放标签、随机对照试验。
Lancet Rheumatol. 2024 Mar;6(3):e168-e177. doi: 10.1016/S2665-9913(23)00320-X. Epub 2024 Jan 29.
6
Can Waves of Autoimmune Diseases Occur after the COVID-19 Pandemic?新冠疫情之后会出现自身免疫性疾病浪潮吗？
Infect Disord Drug Targets. 2024;24(4):67-68. doi: 10.2174/0118715265272448231211101718.
7
Qualitative Proteome-wide Lysine Crotonylation Profiling Reveals Protein Modification Alteration in the Leukocyte Extravasation Pathway in Systemic Lupus Erythematosus.全蛋白质组赖氨酸巴豆酰化定性分析揭示系统性红斑狼疮白细胞外渗途径中的蛋白质修饰改变
ACS Omega. 2023 Nov 14;8(47):44905-44919. doi: 10.1021/acsomega.3c06293. eCollection 2023 Nov 28.
8
Current Treatment Approach, Emerging Therapies and New Horizons in Systemic Lupus Erythematosus.系统性红斑狼疮的当前治疗方法、新兴疗法及新展望
Life (Basel). 2023 Jul 1;13(7):1496. doi: 10.3390/life13071496.
9
Modulation of Autoimmune and Autoinflammatory Diseases by Gasdermins.Gasdermins 在自身免疫性和自身炎症性疾病中的调节作用。
Front Immunol. 2022 Jun 1;13:841729. doi: 10.3389/fimmu.2022.841729. eCollection 2022.
10
Strategies of Targeting Inflammasome in the Treatment of Systemic Lupus Erythematosus.靶向炎症小体治疗系统性红斑狼疮的策略。
Front Immunol. 2022 May 18;13:894847. doi: 10.3389/fimmu.2022.894847. eCollection 2022.
本文引用的文献
1
Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis.免疫抑制药物和糖皮质激素治疗狼疮性肾炎时发生严重感染的风险：一项系统评价和网状Meta分析
BMC Med. 2016 Sep 13;14(1):137. doi: 10.1186/s12916-016-0673-8.
2
Optimising B-cell depletion in autoimmune disease: is obinutuzumab the answer?优化自身免疫性疾病中的B细胞清除：奥妥珠单抗是答案吗？
Drug Discov Today. 2016 Aug;21(8):1330-8. doi: 10.1016/j.drudis.2016.06.009. Epub 2016 Jun 22.
3
Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.先天性和适应性血清介质失调先于系统性红斑狼疮的分类，并提高自身抗体的预后准确性。
J Autoimmun. 2016 Nov;74:182-193. doi: 10.1016/j.jaut.2016.06.001. Epub 2016 Jun 20.
4
Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus.维生素D状态与CYP24A1在系统性红斑狼疮转变过程中的联合作用
Ann Rheum Dis. 2017 Jan;76(1):153-158. doi: 10.1136/annrheumdis-2016-209157. Epub 2016 Jun 9.
5
Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus.诱导型 T 细胞共刺激分子配体 (ICOSL) 阻断导致系统性红斑狼疮患者抗 KLH IgG 反应的选择性抑制。
Lupus Sci Med. 2016 Apr 8;3(1):e000146. doi: 10.1136/lupus-2016-000146. eCollection 2016.
6
Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus.中性粒细胞释放的氧化线粒体类核驱动人类狼疮中I型干扰素的产生。
J Exp Med. 2016 May 2;213(5):697-713. doi: 10.1084/jem.20151876. Epub 2016 Apr 18.
7
T follicular regulatory cells.滤泡辅助性 T 调节细胞。
Immunol Rev. 2016 May;271(1):246-59. doi: 10.1111/imr.12411.
8
Blisibimod for treatment of systemic lupus erythematosus: with trials you become wiser.用于治疗系统性红斑狼疮的布利西莫德：实践出真知。
Expert Opin Biol Ther. 2016;16(5):723-33. doi: 10.1517/14712598.2016.1169270.
9
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients.个性化免疫监测揭示了对狼疮患者进行分层的分子网络。
Cell. 2016 Apr 21;165(3):551-65. doi: 10.1016/j.cell.2016.03.008. Epub 2016 Mar 31.
10
CXCR5 is critically involved in progression of lupus through regulation of B cell and double-negative T cell trafficking.CXCR5通过调节B细胞和双阴性T细胞的迁移，在狼疮进展中起关键作用。
Clin Exp Immunol. 2016 Jul;185(1):22-32. doi: 10.1111/cei.12791. Epub 2016 Apr 18.
Zotero 插件